A novel missense mutation in the HSD3B2 gene, underlying nonsalt-wasting congenital adrenal hyperplasia. new insight into the structure-function relationships of 3β-hydroxysteroid dehidrogenase type II.
暂无分享,去创建一个
A. Turjanski | A. Belgorosky | M. Rivarola | L. Defelipe | M. Baquedano | R. Marino | M. Ciaccio | M. Maceiras | P. Ramírez | N. Pérez Garrido
[1] N. Mahdieh,et al. In silico structural, functional and pathogenicity evaluation of a novel mutation: an overview of HSD3B2 gene mutations. , 2012, Gene.
[2] Z. Hochberg,et al. Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis. , 2012, The Journal of clinical endocrinology and metabolism.
[3] W. Miller,et al. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. , 2011, Endocrine reviews.
[4] R. Auchus,et al. 46,XX DSD: the masculinised female. , 2010, Best practice & research. Clinical endocrinology & metabolism.
[5] V. Pletnev,et al. Identification of Key Amino Acids Responsible for the Substantially Higher Affinities of Human Type 1 3β-Hydroxysteroid Dehydrogenase/Isomerase (3β-HSD1) for Substrates, Coenzymes, and Inhibitors Relative to Human 3β-HSD2* , 2005, Journal of Biological Chemistry.
[6] Jacques Simard,et al. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. , 2005, Endocrine reviews.
[7] Jacques Simard,et al. Molecular Biology of the 3-Hydroxysteroid Dehydrogenase/5-4 Isomerase Gene Family , 2005 .
[8] W. Duax,et al. Structure/Function Relationships Responsible for Coenzyme Specificity and the Isomerase Activity of Human Type 1 3β-Hydroxysteroid Dehydrogenase/Isomerase* , 2003, Journal of Biological Chemistry.
[9] D. Balasubramanian,et al. Mutations , 2003, Human Genetics.
[10] B. Rich,et al. A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia. , 2002, The Journal of clinical endocrinology and metabolism.
[11] M. Forest,et al. New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. , 1999, The Journal of clinical endocrinology and metabolism.
[12] W L Miller,et al. Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes. , 1999, The Journal of clinical endocrinology and metabolism.
[13] S. Pang. The Molecular and Clinical Spectrum of 3β-hydroxysteroid Dehydrogenase Deficiency Disorder , 1998, Trends in Endocrinology & Metabolism.
[14] W. Nash,et al. An NADH-induced Conformational Change That Mediates the Sequential 3β-Hydroxysteroid Dehydrogenase/Isomerase Activities Is Supported by Affinity Labeling and the Time-dependent Activation of Isomerase (*) , 1995, The Journal of Biological Chemistry.
[15] J. Nakae,et al. Molecular analysis of type II 3β-hydroxysteroid dehydrogenase gene in Japanese patients with classical 3β-hydroxysteroid dehydrogenase deficiency , 1995 .
[16] J. Simard,et al. MOLECULAR BASIS OF CONGENITAL ADRENAL HYPERPLASIA DUE TO 3β-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY , 1993, Pediatric Research.
[17] M. Bettendorf,et al. Male psuedohermaphroditism caused by nonsalt-losing congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase (3β-HSD) deficiency , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[18] J. Simard,et al. Structure and Expression of a New Complementary DNA Encoding the almost Exclusive 3β-Hydroxysteroid Dehydrogenase/Δ5-Δ4-lsomerase in Human Adrenals and Gonads , 1991 .
[19] M. Dumont,et al. Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. , 1991, Molecular endocrinology.
[20] M. Volmer,et al. Detection of 3 beta-hydroxysteroid-dehydrogenase deficiency by urinary steroid profiling: solvolysis of urinary samples should be a necessary prerequisite. , 1985, Clinica chimica acta; international journal of clinical chemistry.